Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has reported revenue of US$6.12 million for the six months to December 31 ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Lumos Diagnostics Holdings Ltd. has ...

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Lumos Diagnostics Holdings Ltd has ...

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a further US$720,000 in non-dilutive funding after completing a key enrolment milestone in its ongoing US paediatric clinical study for ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Lumos Diagnostics Holdings ...

Lumos reaches enrolment milestone in a paediatric clinical study assessing use of its FebriDx point of care test, to ...

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...

Short interest in Lumos Diagnostics Holdings Ltd (OTC:LDXHF) decreased during the last reporting period, falling from 51.00K to 6.00K. This put -% of the company's publicly available shares short.

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update. Lumos Diagnostics Holdings Ltd. has successfully carried all resolutions at its 2024 Annual General Meeting, including the re-election ...

Hi, and welcome, everyone. Thank you for joining us today for this outpatient-focused webinar hosted by Lumos Diagnostics as an Antibiotic Stewardship Sponsor of the Urgent Care Association. Today's ...

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional ...

Lawrence L. Mehren is currently the Chairman at Avery Therapeutics, Inc., Deputy Chairman at Lumos Diagnostics Holdings Ltd., and Independent Director at Lumos Diagnostics. He is also a Manager at ...